Quoin Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome, Other Skin Diseases
Quoin Pharmaceuticals has filed a U.S. patent application for novel topical formulations to treat several skin diseases, including Netherton Syndrome (NS). Quoin’s lead product, QRX003, is currently being tested in four Netherton Syndrome clinical trials. Three of these trials are being conducted under Quoin’s open Investigational New Drug (IND) application with the US Food and […]